News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Covidien plc to Report Fourth-Quarter Results on November 9, 2010
September 29, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) will report fourth-quarter results before trading begins on November 9, 2010. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Drug pricing
With MFN now embedded in pharma, execs see little impact from Democrats’ blue wave
November 4, 2026
·
4 min read
·
Annalee Armstrong
Weight loss
Novo, Lilly battle for oral GLP-1 dominance with data tit for tat
November 4, 2026
·
3 min read
·
Annalee Armstrong
Vaccines
Pfizer eyes Europe first for Lyme vaccine as prevalence rises in US
November 4, 2026
·
1 min read
·
Annalee Armstrong
Podcast
Q3 earnings roll on, FDA pushes rare disease, uniQure’s Huntington’s therapy reaches review
November 4, 2026
·
1 min read
·
Jef Akst